Yew Bio Pharm Revenue, Profits - YEWB Annual Income Statement

Add to My Stocks
$0.2 $0 (0%) YEWB stock closing price Aug 18, 2017 (Closing)

Fundamental analysis of YEWB stock involves analyzing its financial statements, apart from checking the Yew Bio Pharm stock price The income statement gives the investor an understanding of the topline and bottomline numbers of the company and helps investors evaluate if a company has been growing or not. The income statement is generated for a specific period of time. The revenue increase of $51.34M for 2016 impacts the YEWB stock. Investors typically check year over year or quarter over quarter revenue growth. Along with Yew Bio Pharm assets and Yew Bio Pharm free cash flow, profits as shown in profit and loss statement give key insights about the business. The profits have decreased from $5.28M YoY and 2016 revenue is $51.34M. Yew Bio Pharm revenue for 2016 is $51.34M. View revenue and profit details for latest and last 10 financial years.

show more
Annual
Quarterly
View Previous Years
View Next Years
Fiscal year is Jan - Dec.201620152014201320122011
Yew Bio Pharm Net Sales or Revenues
51.34M29.57M7.72M7.43M6.72M5.96M
Cost Of Goods Sold (COGS)48.11M22.54M2.13M2.4M1.27M1.12M
Yew Bio Pharm Gross Profit
3.23M7.03M5.58M5.03M5.44M4.83M
Research & Development Expense------
Selling General & Admin Expense1.11M1.89M1.3M1.13M3.24M0.78M
Income Before Depreciation Depletion Amortization2.12M5.13M4.28M3.89M2.2M4.04M
Depreciation Depletion Amortization------
Non Operating Income-0.09M0.16M----0.01M
Interest Expense------
Yew Bio Pharm Pretax Income
2.02M5.3M4.28M3.89M2.2M4.04M
Provision for Income Taxes0.01M0.01M----
Minority Interest------
Investment Gains Losses------
Other Income------
Income Before Extraordinaries & Disc Operations2M5.28M4.28M3.89M2.2M4.04M
Extraordinary Items & Discontinued Operations------
Yew Bio Pharm Net Income (Profit/Loss)
2M5.28M4.28M3.89M2.2M4.04M
Average Shares used to compute Diluted EPS51.88M52.11M----
Average Shares used to compute Basic EPS51.88M52.07M----
Income Before Nonrecurring Items2.01M5.29M----
Income from Nonrecurring Items------
Yew Bio Pharm Earnings Per Share Basic Net
0.040.10----
Yew Bio Pharm Earnings Per Share Diluted Net
0.040.10----
EPS Diluted Before Nonrecurring Items0.040.10----
Preferred Dividends Acc Pd------
Dividends Common------
Dividend Per Share Common------
All figures in USD. M: Millions of USD, B: Billions of USD.
View Previous Years
View Next Years
Get Income statement for another ticker

It is very helpful to read a report on Yew Bio Pharm stock analysis. An investor must check the following items in an income statement:
  • Top line: The word topline comes from the fact that the first line of an income statement refers to sales numbers. If you check you will find that YEWB stock has a topline or revenue of $51.34M for 2016 as per this Yew Bio Pharm revenue chart. Investors look for stocks with a growing top line.
  • Bottom line: The word bottom line comes because it is usually the last line of the income statement and refers to the actual profits after deducting all expenses from the revenues. YEWB stock had a healthy bottom line growth.
The income statement is also called statement of revenue and expense. The financials along with Yew Bio Pharm historical stock prices provides a lot of details about the firm. .

Yew Bio Pharm Income Statement - Key Financial Ratios

PE ratio (price earnings ratio)
8.6960
PS ratio (
price sales ratio
)
0.2050
Operating margin
2.8
Net profit margin
2.2
Dividend yield
0%